Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging

Allan MacKenzie-Graham1, Gilda A Rinek, Andrea Avedisian

  • 1University of California, Los Angeles, Los Angeles, CA, USA. 091593/Z/10/

Neuroimage
|December 21, 2011
PubMed

Insights

This study shows progressive brain atrophy in a mouse model of multiple sclerosis (MS). Longitudinal in vivo MRI imaging revealed significant cortical and cerebellar atrophy, correlating with disease severity.

Area of Science:

  • Neuroscience
  • Radiology
  • Immunology

Background:

  • Cortical atrophy in multiple sclerosis (MS) correlates with disability and disease duration.
  • Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model for MS.

Purpose of the Study:

  • To evaluate the progression of cortical atrophy over time in vivo in the EAE mouse model.
  • To compare in vivo and ex vivo MRI findings in EAE mice.

Main Methods:

  • High-resolution T2-weighted MRI scans were collected in vivo from EAE mice and controls.
  • Brain structures were labeled to quantify volumetric changes over time.
  • Ex vivo MRI and neuropathology were used for cross-modality correlation.

Main Results:

  • All EAE mice showed significant whole brain, cerebral cortex, and cerebellar atrophy compared to controls.
  • Cerebellar atrophy strongly correlated with cumulative disease score.
  • Longitudinal in vivo imaging was more sensitive to neurodegenerative changes than ex vivo imaging.

Conclusions:

  • Progressive cortical atrophy can be detected in vivo in an MS mouse model.
  • Longitudinal in vivo MRI is a sensitive tool for studying neurodegeneration in EAE.
  • Findings support the link between brain atrophy and disease progression in MS models.

Related Concept Videos